Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Mixed lineage kinase 1 (MAP3K9)
|
|
31.338 (89/284) |
1.48E-28 |
Proto-oncogene serine/threonine-protein kinase mos (MOS)
|
|
28.383 (86/303) |
1.40E-22 |
Omphalocele kinase 1 (NUAK1)
|
|
30.000 (75/250) |
2.43E-22 |
Serine/threonine-protein kinase 26 (STK26)
|
|
28.413 (77/271) |
1.13E-21 |
Cyclin-dependent kinase 3 (CDK3)
|
|
29.911 (67/224) |
5.41E-21 |
Microtubule affinity regulating kinase 3 (MARK3)
|
|
28.269 (80/283) |
7.07E-21 |
Leucine-rich repeat kinase 2 (LRRK2)
|
|
28.652 (102/356) |
7.32E-21 |
Oxidative stress responsive 1 (OXSR1)
|
|
28.571 (78/273) |
7.76E-21 |
MAP/microtubule affinity-regulating kinase 4 (MARK4)
|
|
30.736 (71/231) |
8.59E-21 |
NIMA-related kinase 7 (NEK7)
|
|
25.000 (67/268) |
1.91E-20 |
MAPK/ERK kinase kinase 3 (MAP3K3)
|
|
32.487 (64/197) |
6.41E-20 |
Serine/threonine-protein kinase 24 (STK24)
|
|
29.070 (75/258) |
6.53E-20 |
NUAK family SNF1-like kinase 2 (NUAK2)
|
|
28.846 (75/260) |
6.85E-20 |
Serine/threonine-protein kinase 25 (STK25)
|
|
27.519 (71/258) |
1.05E-19 |
Myosin light chain kinase family member 4 (MYLK4)
|
|
32.857 (69/210) |
1.20E-19 |
Ste-20-related kinase (STK39)
|
|
28.041 (83/296) |
1.33E-19 |
NIMA-related kinase 6 (NEK6)
|
|
23.667 (71/300) |
1.58E-19 |
Serine/threonine-protein kinase ULK1 (ULK1)
|
|
31.330 (73/233) |
2.01E-19 |
Serine/threonine-protein kinase ULK2 (ULK2)
|
|
33.178 (71/214) |
2.13E-19 |
Serine/threonine-protein kinase NIM1 (NIM1K)
|
|
30.000 (75/250) |
2.73E-19 |
Stress-activated protein kinase 2a (p38 alpha)
|
|
27.559 (70/254) |
2.92E-19 |
MAPK/ERK kinase kinase 2 (MAP3K2)
|
|
29.386 (67/228) |
3.96E-19 |
Serine/threonine-protein kinase MARK1 (MARK1)
|
|
29.437 (68/231) |
5.09E-19 |
Cyclin-dependent kinase 2 (CDK2)
|
|
27.381 (69/252) |
5.30E-19 |
Salt-inducible kinase 2 (SIK2)
|
|
32.110 (70/218) |
6.12E-19 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
|
29.245 (62/212) |
9.09E-19 |
MST-1 protein kinase (STK4)
|
|
26.877 (68/253) |
1.21E-18 |
Myosin light chain kinase 2 (MYLK2)
|
|
30.909 (68/220) |
1.70E-18 |
Serine/threonine-protein kinase MARK2 (MARK2)
|
|
29.646 (67/226) |
1.75E-18 |
Serine/threonine-protein kinase Nek5 (NEK5)
|
|
23.019 (61/265) |
1.77E-18 |
Myosin-IIIa (MYO3A)
|
|
27.402 (77/281) |
2.35E-18 |
TRAF2 and NCK interacting kinase (TNIK)
|
|
26.368 (53/201) |
2.87E-18 |
Stress-activated protein kinase 2b (p38 beta)
|
|
28.151 (67/238) |
5.29E-18 |
Misshapen-like kinase 1 (MINK1)
|
|
26.087 (54/207) |
5.56E-18 |
Polo-like kinase 2 (PLK2)
|
|
27.734 (71/256) |
5.59E-18 |
Cyclin-dependent kinase 15 (CDK15)
|
|
30.736 (71/231) |
6.11E-18 |
BR serine/threonine kinase 2 (BRSK2)
|
|
29.536 (70/237) |
6.77E-18 |
Cyclin-dependent kinase 14 (CDK14)
|
|
30.568 (70/229) |
8.25E-18 |
Serine/threonine-protein kinase 3 (STK3)
|
|
26.877 (68/253) |
9.62E-18 |
MAP kinase p38 (MAPK12)
|
|
29.333 (66/225) |
1.14E-17 |
MEK kinase kinase 4 (MAP4K4)
|
|
26.570 (55/207) |
1.18E-17 |
BR serine/threonine kinase 1 (BRSK1)
|
|
28.627 (73/255) |
1.25E-17 |
Putative serine/threonine-protein kinase SIK1B (SIK1B)
|
|
30.275 (66/218) |
2.04E-17 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2)
|
|
28.638 (61/213) |
2.07E-17 |
Salt-inducible kinase 1 (SIK1)
|
|
30.275 (66/218) |
2.15E-17 |
Serine/threonine-protein kinase Nek8 (NEK8)
|
|
26.295 (66/251) |
2.70E-17 |
Protein kinase C theta (PRKCQ)
|
|
29.333 (66/225) |
4.82E-17 |
Serine/threonine-protein kinase PAK 6 (PAK6)
|
|
25.541 (59/231) |
5.39E-17 |
SIK family kinase 3 (SIK3)
|
|
30.734 (67/218) |
5.88E-17 |
Cyclin-dependent kinase 16 (CDK16)
|
|
30.222 (68/225) |
6.24E-17 |
Serine/threonine-protein kinase ICK (CILK1)
|
|
32.381 (68/210) |
6.74E-17 |
Serine/threonine-protein kinase TAO2 (TAOK2)
|
|
27.778 (70/252) |
9.57E-17 |
Aurora kinase C (AURKC)
|
|
28.395 (69/243) |
1.07E-16 |
Aurora kinase A (AURKA)
|
|
27.037 (73/270) |
1.07E-16 |
Cyclin-dependent kinase 17 (CDK17)
|
|
29.515 (67/227) |
1.38E-16 |
Protein kinase N2 (PKN2)
|
|
30.870 (71/230) |
1.44E-16 |
Serine/threonine-protein kinase PAK 5 (PAK5)
|
|
24.631 (50/203) |
1.72E-16 |
Mitogen-activated protein kinase 13 (MAPK13)
|
|
30.698 (66/215) |
2.02E-16 |
Unc-51 like kinase 3 (ULK3)
|
|
29.730 (66/222) |
2.47E-16 |
Myosin light chain kinase 3 (MYLK3)
|
|
31.401 (65/207) |
3.41E-16 |
Cyclin-dependent kinase 12 (CDK12)
|
|
29.557 (60/203) |
4.48E-16 |
Serine/threonine-protein kinase MAK (MAK)
|
|
30.392 (62/204) |
4.89E-16 |
Serine/threonine-protein kinase Nek4 (NEK4)
|
|
27.099 (71/262) |
5.19E-16 |
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)
|
|
27.586 (72/261) |
6.48E-16 |
Ribosomal protein S6 kinase alpha-3 (RSK3)
|
|
26.772 (68/254) |
6.93E-16 |
Ribosomal protein S6 kinase alpha-1 (RSK1)
|
|
28.311 (62/219) |
7.67E-16 |
Protein kinase G2 (PRKG2)
|
|
28.740 (73/254) |
7.72E-16 |
Cyclin-dependent kinase 5 (CDK5)
|
|
27.753 (63/227) |
8.08E-16 |
Myosin light kinase (MYLK)
|
|
30.769 (64/208) |
8.34E-16 |
Extracellular signal-regulated kinase 2 (ERK2)
|
|
28.780 (59/205) |
1.14E-15 |
Ribosomal protein S6 kinase alpha-2 (RSK2)
|
|
29.091 (64/220) |
1.63E-15 |
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5)
|
|
25.540 (71/278) |
1.91E-15 |
Serine/threonine-protein kinase Nek9 (NEK9)
|
|
23.904 (60/251) |
2.03E-15 |
Cyclin-dependent kinase 13 (CDK13)
|
|
29.327 (61/208) |
2.40E-15 |
NIMA-related kinase 2 (NEK2)
|
|
26.027 (57/219) |
2.66E-15 |
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA)
|
|
28.326 (66/233) |
2.89E-15 |
PAK-4 protein kinase (PAK4)
|
|
25.123 (51/203) |
2.91E-15 |
Extracellular signal-regulated kinase 1 (ERK1)
|
|
29.327 (61/208) |
2.97E-15 |
ERK activator kinase 5 (MAP2K5)
|
|
27.306 (74/271) |
3.17E-15 |
Serine/threonine-protein kinase Nek11 (NEK11)
|
|
25.600 (64/250) |
3.38E-15 |
Protein kinase C delta (PRKCD)
|
|
31.429 (66/210) |
3.90E-15 |
Maternal embryonic leucine zipper kinase (MELK)
|
|
29.279 (65/222) |
3.95E-15 |
Serine/threonine-protein kinase 33 (STK33)
|
|
29.596 (66/223) |
4.10E-15 |
Checkpoint kinase-1 (CHK1)
|
|
29.353 (59/201) |
4.31E-15 |
Serine/threonine-protein kinase PLK3 (PLK3)
|
|
25.581 (66/258) |
4.81E-15 |
TAO kinase 1 (TAOK1)
|
|
25.912 (71/274) |
5.36E-15 |
SNF-related serine/threonine-protein kinase (SNRK)
|
|
28.638 (61/213) |
5.52E-15 |
Serine/threonine-protein kinase Nek3 (NEK3)
|
|
24.016 (61/254) |
9.24E-15 |
PKC-delta-interacting protein kinase (RIPK4)
|
|
29.123 (83/285) |
9.54E-15 |
Serine/threonine-protein kinase SBK1 (SBK1)
|
|
27.570 (59/214) |
1.18E-14 |
MAPK/ERK kinase kinase 4 (MAP3K4)
|
|
26.172 (67/256) |
1.63E-14 |
MEK kinase kinase 1 (MAP4K1)
|
|
26.733 (54/202) |
1.64E-14 |
MEK kinase kinase 3 (MAP4K3)
|
|
24.151 (64/265) |
1.75E-14 |
Mitogen-activated protein kinase 4 (MAPK4)
|
|
31.443 (61/194) |
1.97E-14 |
Ribosomal protein S6 kinase alpha-6 (RSK6)
|
|
26.364 (58/220) |
2.04E-14 |
Serine/threonine-protein kinase PAK 3 (PAK3)
|
|
26.214 (54/206) |
2.11E-14 |
Serine/threonine-protein kinase Sgk1 (SGK1)
|
|
27.650 (60/217) |
2.66E-14 |
NIMA-related kinase 1 (NEK1)
|
|
21.324 (58/272) |
2.69E-14 |
PAK-1 protein kinase (PAK1)
|
|
25.728 (53/206) |
3.00E-14 |
Cyclin-dependent kinase 7 (CDK7)
|
|
29.741 (69/232) |
3.12E-14 |
PAK-2 protein kinase (PAK2)
|
|
26.214 (54/206) |
3.80E-14 |
Testis-specific serine/threonine-protein kinase 4 (TSSK4)
|
|
24.481 (59/241) |
4.19E-14 |
Serine/threonine-protein kinase 17B (STK17B)
|
|
27.451 (70/255) |
4.40E-14 |
Testis-specific serine kinase 2 (TSSK2)
|
|
25.926 (63/243) |
4.46E-14 |
Cyclin-dependent kinase 18 (CDK18)
|
|
29.018 (65/224) |
4.63E-14 |
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
|
|
26.437 (69/261) |
5.02E-14 |
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)
|
|
26.829 (66/246) |
5.47E-14 |
Fused homolog (STK36)
|
|
26.000 (52/200) |
6.97E-14 |
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG)
|
|
27.700 (59/213) |
7.17E-14 |
Cyclin-dependent kinase-like 3 (CDKL3)
|
|
30.612 (60/196) |
7.56E-14 |
Death-associated protein kinase 1 (DAPK1)
|
|
28.899 (63/218) |
8.70E-14 |
Cyclin-dependent kinase 9 (CDK9)
|
|
28.293 (58/205) |
8.91E-14 |
SPS1/STE20-related protein kinase YSK4 (YSK4)
|
|
24.806 (64/258) |
1.35E-13 |
IL-1 receptor-associated kinase 1 (IRAK1)
|
|
26.442 (55/208) |
1.39E-13 |
Serine/threonine-protein kinase D3 (PRKD3)
|
|
30.303 (60/198) |
1.82E-13 |
Cyclin-dependent kinase 1 (CDK1)
|
|
24.352 (47/193) |
2.06E-13 |
Apoptosis signal-regulating kinase 1 (MAP3K5)
|
|
24.113 (68/282) |
2.26E-13 |
Serine/threonine-protein kinase D2 (PRKD2)
|
|
29.798 (59/198) |
2.27E-13 |
Cyclin-dependent kinase-like 2 (CDKL2)
|
|
31.863 (65/204) |
2.51E-13 |
Protein kinase C beta (PRKCB)
|
|
28.910 (61/211) |
2.52E-13 |
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)
|
|
27.885 (58/208) |
2.60E-13 |
ERK activator kinase 7 (MAP2K7)
|
|
29.064 (59/203) |
2.65E-13 |
Protein kinase C epsilon (PRKCE)
|
|
25.463 (55/216) |
2.67E-13 |
Death-associated protein kinase 3 (DAPK3)
|
|
26.389 (57/216) |
2.83E-13 |
Protein kinase C alpha (PRKCA)
|
|
26.383 (62/235) |
3.42E-13 |
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
|
|
26.190 (55/210) |
3.48E-13 |
Aurora kinase B (AURKB)
|
|
26.446 (64/242) |
3.72E-13 |
Mitogen-activated protein kinase 6 (MAPK6)
|
|
26.977 (58/215) |
4.65E-13 |
ERK activator kinase 2 (MEK2)
|
|
27.273 (57/209) |
6.27E-13 |
Hormonally up-regulated neu tumor-associated kinase (HUNK)
|
|
27.941 (57/204) |
6.61E-13 |
Protein kinase G1 (PRKG1)
|
|
26.721 (66/247) |
7.51E-13 |
Protein kinase D (PRKD1)
|
|
29.798 (59/198) |
8.82E-13 |
ERK activator kinase 1 (MEK1)
|
|
26.761 (57/213) |
9.57E-13 |
Cyclin-dependent kinase 6 (CDK6)
|
|
27.184 (56/206) |
1.12E-12 |
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
|
24.014 (67/279) |
1.31E-12 |
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
|
24.080 (72/299) |
1.31E-12 |
Protein kinase N1 (PKN1)
|
|
29.412 (65/221) |
1.47E-12 |
Apoptosis signal-regulating kinase 2 (MAP3K6)
|
|
25.893 (58/224) |
1.51E-12 |
TGF-beta receptor type I (TGFBR1)
|
|
26.484 (58/219) |
1.55E-12 |
Death-associated protein kinase 2 (DAPK2)
|
|
26.389 (57/216) |
1.72E-12 |
Serine/threonine-protein kinase STK11 (STK11)
|
|
27.885 (58/208) |
1.73E-12 |
Activin receptor type IB (ACVR1B)
|
|
26.484 (58/219) |
1.75E-12 |
G protein-coupled receptor kinase 5 (GRK5)
|
|
27.700 (59/213) |
1.97E-12 |
Protein kinase C gamma (PRKCG)
|
|
26.050 (62/238) |
2.29E-12 |
Phosphoinositide dependent protein kinase-1 (PDPK1)
|
|
25.000 (50/200) |
2.44E-12 |
Polo-like kinase 1 (PLK1)
|
|
24.786 (58/234) |
2.56E-12 |
Serine/threonine-protein kinase Sgk2 (SGK2)
|
|
26.168 (56/214) |
2.81E-12 |
Cyclin-dependent kinase 10 (CDK10)
|
|
27.805 (57/205) |
2.92E-12 |
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P)
|
|
25.000 (50/200) |
2.97E-12 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
|
26.087 (66/253) |
4.14E-12 |
Ribosomal protein S6 kinase beta-1 (S6K1)
|
|
25.455 (56/220) |
4.47E-12 |
Cyclin-dependent kinase-like 1 (CDKL1)
|
|
27.536 (57/207) |
4.78E-12 |
Serine/threonine-protein kinase MRCK beta (CDC42BPB)
|
|
25.952 (75/289) |
4.91E-12 |
TAO kinase 3 (TAOK3)
|
|
27.344 (70/256) |
5.63E-12 |
WNK lysine-deficient protein kinase 3 (WNK3)
|
|
26.772 (68/254) |
6.77E-12 |
Protein kinase C eta type (PRKCH)
|
|
26.341 (54/205) |
8.67E-12 |
Homeodomain-interacting protein kinase 4 (HIPK4)
|
|
26.754 (61/228) |
9.40E-12 |
Cytoplasmic DRAK1 (STK17A)
|
|
27.442 (59/215) |
9.57E-12 |
Serine/threonine-protein kinase SBK2 (SBK2)
|
|
30.653 (61/199) |
1.05E-11 |
Serine/threonine-protein kinase 10 (STK10)
|
|
27.053 (56/207) |
1.45E-11 |
Citron Rho-interacting kinase (CIT)
|
|
28.507 (63/221) |
1.53E-11 |
Serine/threonine-protein kinase WNK1 (WNK1)
|
|
27.273 (69/253) |
1.60E-11 |
Polo-like kinase 4 (PLK4)
|
|
26.020 (51/196) |
1.66E-11 |
Cyclin-dependent kinase-like 4 (CDKL4)
|
|
27.803 (62/223) |
1.76E-11 |
Testis-specific serine/threonine-protein kinase 6 (TSSK6)
|
|
27.381 (69/252) |
1.88E-11 |
MAPK/ERK kinase kinase 1 (MAP3K1)
|
|
26.502 (75/283) |
1.98E-11 |
STE20-related serine/threonine-protein kinase (SLK)
|
|
28.704 (62/216) |
2.01E-11 |
Serine/threonine-protein kinase Sgk3 (SGK3)
|
|
26.852 (58/216) |
2.24E-11 |
Ribosomal protein S6 kinase beta-2 (RPS6KB2)
|
|
24.206 (61/252) |
2.34E-11 |
Testis-specific serine/threonine-protein kinase 3 (TSSK3)
|
|
25.333 (57/225) |
2.40E-11 |
Stress-activated protein kinase JNK1 (JNK1)
|
|
28.571 (60/210) |
4.13E-11 |
Stress-activated protein kinase JNK3 (JNK3)
|
|
28.095 (59/210) |
4.19E-11 |
Testis-specific serine/threonine-protein kinase 1 (TSSK1B)
|
|
24.686 (59/239) |
4.34E-11 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A)
|
|
26.457 (59/223) |
4.76E-11 |
RAC-gamma serine/threonine-protein kinase (AKT3)
|
|
28.856 (58/201) |
4.82E-11 |
Cyclin-dependent kinase 20 (CDK20)
|
|
25.000 (58/232) |
6.02E-11 |
Cyclin-dependent kinase 11B (CDK11B)
|
|
27.027 (60/222) |
6.52E-11 |
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B)
|
|
26.570 (55/207) |
6.85E-11 |
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)
|
|
25.628 (51/199) |
9.98E-11 |
Serine/threonine-protein kinase tousled-like 1 (TLK1)
|
|
31.579 (54/171) |
9.98E-11 |
Tyrosine-protein kinase EIF2AK2 (p68)
|
|
24.865 (46/185) |
1.02E-10 |
Cyclin-dependent kinase-like 5 (CDKL5)
|
|
26.000 (52/200) |
1.05E-10 |
Serine/threonine-protein kinase 32A (STK32A)
|
|
24.473 (58/237) |
1.06E-10 |
G protein-coupled receptor kinase 6 (GRK6)
|
|
26.087 (54/207) |
1.09E-10 |
Cyclin-dependent kinase 11A (CDK11A)
|
|
27.876 (63/226) |
1.17E-10 |
Myosin-IIIb (MYO3B)
|
|
23.381 (65/278) |
1.19E-10 |
Serine/threonine-protein kinase pim-1 (PIM1)
|
|
26.429 (74/280) |
1.21E-10 |
Doublecortin-like kinase 1 (DCLK1)
|
|
22.747 (53/233) |
1.23E-10 |
Extracellular signal-regulated kinase 5 (ERK5)
|
|
25.000 (56/224) |
1.30E-10 |
G protein-coupled receptor kinase 4 (GRK4)
|
|
26.087 (54/207) |
1.43E-10 |
Serine/threonine-protein kinase tousled-like 2 (TLK2)
|
|
31.977 (55/172) |
1.57E-10 |
Ribosomal protein S6 kinase alpha-5 (RSK5)
|
|
26.316 (65/247) |
1.59E-10 |
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
|
|
27.962 (59/211) |
1.71E-10 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)
|
|
28.511 (67/235) |
1.78E-10 |
Serine/threonine-protein kinase H2 (PSKH2)
|
|
25.676 (57/222) |
2.00E-10 |
CDC42 binding protein kinase alpha (DMPK-like alpha)
|
|
26.786 (75/280) |
2.04E-10 |
Serine/threonine-protein kinase Chk2 (RAD53)
|
|
27.805 (57/205) |
2.54E-10 |
Calcium/calmodulin-dependent protein kinase type IV (CAMK4)
|
|
28.804 (53/184) |
2.83E-10 |
Serine/threonine-protein kinase pim-2 (PIM2)
|
|
25.670 (67/261) |
3.03E-10 |
Rho-associated protein kinase 1 (ROCK1)
|
|
29.187 (61/209) |
3.56E-10 |
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
|
23.789 (54/227) |
4.35E-10 |
Calmodulin-dependent kinase II (CAMKK2)
|
|
26.293 (61/232) |
4.75E-10 |
Serine/threonine-protein kinase 32C (STK32C)
|
|
26.339 (59/224) |
4.92E-10 |
Serine/threonine-protein kinase WNK2 (WNK2)
|
|
27.165 (69/254) |
5.45E-10 |
Doublecortin-like kinase 3 (DCLK3)
|
|
24.339 (46/189) |
5.89E-10 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
|
25.581 (66/258) |
6.55E-10 |
Serine/threonine-protein kinase Nek10 (NEK10)
|
|
23.529 (64/272) |
6.75E-10 |
Putative serine/threonine-protein kinase PRKY (PRKY)
|
|
26.702 (51/191) |
7.35E-10 |
Rho-associated protein kinase 2 (ROCK2)
|
|
28.986 (60/207) |
1.06E-09 |
TBC domain-containing protein kinase-like protein (TBCK)
|
|
25.532 (60/235) |
1.08E-09 |
Stress-activated protein kinase JNK2 (JNK2)
|
|
26.761 (57/213) |
1.23E-09 |
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1)
|
|
27.041 (53/196) |
1.25E-09 |
Mitogen-activated protein kinase 15 (MAPK15)
|
|
26.364 (58/220) |
1.41E-09 |
RAC-beta serine/threonine-protein kinase (AKT2)
|
|
25.301 (63/249) |
1.43E-09 |
Rhodopsin kinase GRK7 (GRK7)
|
|
28.986 (60/207) |
1.52E-09 |
Serine/threonine-protein kinase NLK (NLK)
|
|
27.363 (55/201) |
1.53E-09 |
Anti-mullerian hormone II receptor (AMHR2)
|
|
24.251 (81/334) |
1.64E-09 |
IL-1 receptor-associated kinase 3 (IRAK3)
|
|
28.780 (59/205) |
1.72E-09 |
Cyclin-dependent kinase 4 (CDK4)
|
|
25.373 (51/201) |
2.00E-09 |
CaM-kinase IV kinase (CAMKK1)
|
|
28.834 (47/163) |
2.22E-09 |
Kalirin (KALRN)
|
|
24.900 (62/249) |
2.23E-09 |
Membrane-associated kinase (PKMYT1)
|
|
27.200 (68/250) |
2.37E-09 |
Serine/threonine-protein kinase WNK4 (WNK4)
|
|
27.652 (73/264) |
2.47E-09 |
Yet another novel kinase 2 (STK32B)
|
|
24.091 (53/220) |
2.49E-09 |
Bone morphogenetic protein receptor (BMPR2)
|
|
23.387 (58/248) |
2.76E-09 |
PRKR-like endoplasmic reticulum kinase (PERK)
|
|
28.926 (35/121) |
3.94E-09 |
MAPK/MAK/MRK overlapping kinase (MOK)
|
|
25.112 (56/223) |
3.96E-09 |
Cyclin-dependent kinase 19 (CDK19)
|
|
26.341 (54/205) |
4.10E-09 |
PAS domain-containing serine/threonine-protein kinase (PASK)
|
|
25.481 (53/208) |
4.31E-09 |
Sugen kinase 110 (SBK3)
|
|
28.947 (44/152) |
4.47E-09 |
Doublecortin-like kinase 2 (DCLK2)
|
|
22.066 (47/213) |
4.94E-09 |
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)
|
|
24.887 (55/221) |
5.45E-09 |
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D)
|
|
24.528 (52/212) |
5.73E-09 |
Calcium/calmodulin-dependent protein kinase type 1B (PNCK)
|
|
25.352 (54/213) |
6.18E-09 |
Serine/threonine-protein kinase PRP4 homolog (PRPF4B)
|
|
25.472 (54/212) |
6.72E-09 |
Homeodomain-interacting protein kinase 1 (HIPK1)
|
|
26.522 (61/230) |
6.98E-09 |
MEK kinase kinase 2 (MAP4K2)
|
|
20.000 (40/200) |
8.45E-09 |
Nik-related protein kinase (NRK)
|
|
19.048 (44/231) |
9.02E-09 |
Calcium/calmodulin-dependent protein kinase type 1G (CAMK1G)
|
|
24.268 (58/239) |
1.03E-08 |
Casein kinase I alpha (CSNK1A1)
|
|
24.199 (68/281) |
1.23E-08 |
Protein kinase C zeta (PRKCZ)
|
|
24.786 (58/234) |
1.31E-08 |
RAC-alpha serine/threonine-protein kinase (AKT1)
|
|
25.000 (65/260) |
1.35E-08 |
PDZ binding kinase (PBK)
|
|
25.000 (43/172) |
1.39E-08 |
Protein kinase C iota (PRKCI)
|
|
26.050 (62/238) |
1.53E-08 |
Cyclin-dependent kinase 8 (CDK8)
|
|
25.854 (53/205) |
1.78E-08 |
Homeodomain interacting protein kinase 2 (HIPK2)
|
|
26.906 (60/223) |
1.80E-08 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHKG1)
|
|
26.347 (44/167) |
1.89E-08 |
Tau-tubulin kinase 2 (TTBK2)
|
|
23.556 (53/225) |
2.26E-08 |
Protein kinase N3 (PKN3)
|
|
29.630 (72/243) |
2.37E-08 |
Ribosomal protein S6 kinase-related protein (RSKR)
|
|
32.292 (31/96) |
2.51E-08 |
Activin receptor type IIB (ACVR2B)
|
|
22.018 (48/218) |
2.56E-08 |
Serine/threonine kinase-like domain-containing protein STKLD1 (STKLD1)
|
|
27.551 (27/98) |
3.36E-08 |
Homeodomain-interacting protein kinase 3 (HIPK3)
|
|
26.906 (60/223) |
3.41E-08 |
Serine/threonine-protein kinase NIK (MAP3K14)
|
|
27.919 (55/197) |
3.68E-08 |
Casein kinase I delta (CSNK1D)
|
|
24.815 (67/270) |
5.55E-08 |
Casein kinase I epsilon (CSNK1E)
|
|
24.815 (67/270) |
7.44E-08 |
Microtubule-associated serine/threonine-protein kinase 3 (MAST3)
|
|
21.453 (62/289) |
7.96E-08 |
Dual specificity protein kinase TTK (MPS1)
|
|
23.396 (62/265) |
8.11E-08 |
Serine/threonine-protein kinase greatwall (MASTL)
|
|
26.087 (42/161) |
8.90E-08 |
Activin receptor type IIA (ACVR2A)
|
|
25.243 (52/206) |
9.74E-08 |
Rhodopsin kinase GRK1 (GRK1)
|
|
25.114 (55/219) |
9.86E-08 |
Dual-specificity tyrosine-phosphorylation regulated kinase 4 (DYRK4)
|
|
25.472 (54/212) |
1.03E-07 |
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1)
|
|
29.697 (49/165) |
1.04E-07 |
Interleukin-1 receptor-associated kinase-like 2 (IRAK2)
|
|
23.445 (49/209) |
1.09E-07 |
CDC-like kinase 3 (CLK3)
|
|
23.581 (54/229) |
1.23E-07 |
Endoplasmic reticulum to nucleus signaling 1 (ERN1)
|
|
22.927 (47/205) |
1.23E-07 |
PIM-3 protein kinase (PIM3)
|
|
26.953 (69/256) |
1.24E-07 |
Tau-tubulin kinase (TTBK1)
|
|
24.390 (60/246) |
1.29E-07 |
Striated muscle preferentially expressed protein kinase (SPEG)
|
|
25.949 (41/158) |
1.36E-07 |
Myotonin-protein kinase (DMPK)
|
|
24.609 (63/256) |
1.38E-07 |
Serine/threonine-protein kinase LATS1 (LATS1)
|
|
26.230 (48/183) |
1.61E-07 |
Titin (TTN)
|
21.860 (47/215) |
1.62E-07 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B)
|
|
25.500 (51/200) |
1.73E-07 |
Microtubule-associated serine/threonine-protein kinase 4 (MAST4)
|
|
22.794 (62/272) |
1.77E-07 |
Serine/threonine-protein kinase MRCK gamma (CDC42BPG)
|
|
24.885 (54/217) |
1.81E-07 |
Casein kinase I isoform alpha-like (CSNK1A1L)
|
|
23.132 (65/281) |
2.13E-07 |
Serine/threonine-protein kinase cot (COT)
|
|
22.993 (63/274) |
2.20E-07 |
Serine/threonine-protein kinase H1 (PSKH1)
|
|
24.885 (54/217) |
2.52E-07 |
BMP-2-inducible protein kinase (BMP2K)
|
|
22.273 (49/220) |
2.64E-07 |
TGF-beta-stimulated factor 1 (STK16)
|
|
22.909 (63/275) |
3.52E-07 |
STE20-related kinase adapter protein alpha (STRADA)
|
|
23.529 (40/170) |
4.52E-07 |
Obscurin (OBSCN)
|
|
26.154 (51/195) |
6.14E-07 |
Large tumor suppressor homolog 2 (LATS2)
|
|
27.083 (39/144) |
8.98E-07 |
Cyclin-G-associated kinase (GAK)
|
|
25.279 (68/269) |
9.71E-07 |
Glycogen synthase kinase-3 alpha (GSK-3A)
|
|
27.315 (59/216) |
9.77E-07 |
Wee1-like protein kinase (WEE1)
|
|
24.345 (65/267) |
1.01E-06 |
CDC-like kinase 4 (CLK4)
|
|
23.529 (52/221) |
1.05E-06 |
Microtubule-associated serine/threonine-protein kinase 2 (MAST2)
|
|
22.581 (49/217) |
1.28E-06 |
MAPK-activated protein kinase 2 (MAPKAPK2)
|
|
25.283 (67/265) |
1.64E-06 |
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
|
|
27.962 (59/211) |
1.67E-06 |
Phosphorylase kinase testis gamma 2 (PHKG2)
|
|
23.116 (46/199) |
2.59E-06 |
STE20-related kinase adapter protein beta (STRADB)
|
|
21.429 (48/224) |
3.30E-06 |
Wee1-like protein kinase 2 (WEE2)
|
|
23.333 (70/300) |
3.39E-06 |
CDC-like kinase 1 (CLK1)
|
|
25.000 (59/236) |
3.49E-06 |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2)
|
|
21.827 (43/197) |
6.32E-06 |
Serine/threonine-protein kinase/endoribonuclease IRE2 (ERN2)
|
|
21.849 (52/238) |
6.53E-06 |
NF-kappa-B-activating kinase (TBK1)
|
|
24.348 (56/230) |
7.46E-06 |
CDC-like kinase 2 (CLK2)
|
|
21.402 (58/271) |
7.63E-06 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A)
|
|
25.000 (50/200) |
8.17E-06 |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3)
|
|
21.186 (50/236) |
8.26E-06 |
Microtubule-associated serine/threonine-protein kinase 1 (MAST1)
|
|
20.737 (45/217) |
2.01E-05 |
Serine/threonine-protein kinase Kist (UHMK1)
|
|
26.064 (49/188) |
2.01E-05 |
Adaptor-associated kinase 1 (AAK1)
|
|
21.778 (49/225) |
2.03E-05 |
Glycogen synthase kinase-3 beta (GSK-3B)
|
|
26.291 (56/213) |
3.48E-05 |
Serine/threonine-protein kinase PDIK1L (PDIK1L)
|
|
27.193 (31/114) |
4.14E-05 |
MAPK-activated protein kinase 5 (MAPKAPK5)
|
|
21.754 (62/285) |
5.39E-05 |
Beta-adrenergic receptor kinase 1 (ADRBK1)
|
|
24.569 (57/232) |
6.06E-05 |
SRSF protein kinase 1 (SRPK1)
|
|
27.273 (39/143) |
8.80E-05 |
Beta-adrenergic receptor kinase 2 (ADRBK2)
|
|
24.138 (56/232) |
9.25E-05 |
NDR1 protein kinase (STK38)
|
|
24.000 (36/150) |
1.67E-04 |
MAPK-activated protein kinase 3 (MAPKAPK3)
|
|
21.074 (51/242) |
1.77E-04 |
Serine/threonine-protein kinase ULK4 (ULK4)
|
|
20.614 (47/228) |
2.17E-04 |
CaM kinase-like vesicle-associated protein (CAMKV)
|
|
24.260 (41/169) |
2.47E-04 |
Serine/threonine-protein kinase 35 (STK35)
|
|
26.087 (30/115) |
3.46E-04 |
RelA-associated inhibitor (PPP1R13L)
|
|
36.923 (24/65) |
4.77E-04 |
SH3 and cysteine-rich domain-containing protein (STAC)
|
|
34.483 (20/58) |
5.59E-04 |
NDR2 protein kinase (STK38L)
|
|
22.000 (33/150) |
5.97E-04 |
Proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)
|
|
37.736 (20/53) |
1.00E-03 |
Rho guanine nucleotide exchange factor 38 (ARHGEF38)
|
|
26.984 (17/63) |
1.00E-03 |
Serine/threonine-protein kinase VRK1 (VRK1)
|
|
25.140 (45/179) |
2.00E-03 |
Casein kinase II alpha (CSNK2A1)
|
|
20.202 (40/198) |
3.00E-03 |
SRSF protein kinase 3 (SRPK3)
|
|
24.324 (45/185) |
4.00E-03 |
Click to Show/Hide the Information of Human Similarity Proteins |